Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Lasofoxifene Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Lasofoxifene Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Letrozole Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Metformin Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Metformin Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Metformin Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
N-DESMETHYL-4-HYDROXYTAMOXIFEN Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
N-DESMETHYL-4-HYDROXYTAMOXIFEN Ductal Breast Carcinoma In Situ	QuantumLeap Healthcare Collaborative	P2	CCC (53)
N-DESMETHYL-4-HYDROXYTAMOXIFEN Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
N-DESMETHYL-4-HYDROXYTAMOXIFEN Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Neratinib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Neratinib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Neratinib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Niraparib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Niraparib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Niraparib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Olaparib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Olaparib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Olaparib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Pembrolizumab Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Pembrolizumab Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Pexidartinib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Pexidartinib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Pexidartinib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Rilvegostomig Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)

Showing 51 to 75 of 278 assets

PreviousPage 3 of 12Next